Table 2.

Description of the Randomized Participants at Baseline

Characteristics Mean±SD or n (%)	Total (N= 23)	Treatment Group
		Active CPAP n=12	Sham-CPAP n=11	p-value
Sex
Male	61% (14)	58% (7)	64% (7)	.795
Female	39% (9)	42% (5)	36% (4)
Race			2
White	48% (11)	58% (7)	37% (4)	.292
Black/Biracial *	52% (12)	42% (5)	63% (7)
Education
≤ High School	48% (11)	50% (6)	46% (5)	.510
> High School	52% (12)	50% (6)	54% (6)
Comorbidities †
0–3	56% (13)	50% (6)	64% (7)	.762
4 or more	44% (10)	50% (6)	36% (4)

^*One participant identified biracial Black and Native American

^†Comorbidities diagnosed by health care provider, possible range from 0–17.